Alpha 2.0
Login Register
» Authors » D Albanes

D Albanes

Explore the profile of D Albanes including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 151
Citations 3843
Followers 0
Related Specialties
Oncology
Public Health
Nutritional Sciences
Top 10 Co-Authors
J Virtamo
P R Taylor
O P Heinonen
P Pietinen
J K HUTTUNEN
J A Tangrea
M Rautalahti
T J Hartman
S J Weinstein
A M Hartman
Published In
Cancer Causes Control
Am J Epidemiol
Eur J Clin Nutr
Nutr Cancer
Am J Clin Nutr
Affiliations
Soon will be listed here.
Recent Articles
1.
Corrigendum to 'Measures of body fatness and height in early and mid-to-late adulthood and prostate cancer: risk and mortality in The Pooling Project of Prospective Studies of Diet and Cancer': [Annals of Oncology Volume 31, Issue 1, January 2020,...
Genkinger J, Wu K, Wang M, Albanes D, BLACK A, van den Brandt P, et al.
Ann Oncol . 2021 Jul; 32(9):1201. PMID: 34244036
No abstract available.
2.
Measures of body fatness and height in early and mid-to-late adulthood and prostate cancer: risk and mortality in The Pooling Project of Prospective Studies of Diet and Cancer
Genkinger J, Wu K, Wang M, Albanes D, BLACK A, van den Brandt P, et al.
Ann Oncol . 2020 Jan; 31(1):103-114. PMID: 31912782
Background: Advanced prostate cancer etiology is poorly understood. Few studies have examined associations of anthropometric factors (e.g. early adulthood obesity) with advanced prostate cancer risk. Patients And Methods: We carried...
3.
Timing of HPV16-E6 antibody seroconversion before OPSCC: findings from the HPVC3 consortium
Kreimer A, Ferreiro-Iglesias A, Nygard M, Bender N, Schroeder L, Hildesheim A, et al.
Ann Oncol . 2019 Jun; 30(8):1335-1343. PMID: 31185496
Background: Human papillomavirus type 16 (HPV16)-E6 antibodies are detectable in peripheral blood before diagnosis in the majority of HPV16-driven oropharyngeal squamous cell carcinoma (OPSCC), but the timing of seroconversion is...
4.
Vitamin B6 catabolism and lung cancer risk: results from the Lung Cancer Cohort Consortium (LC3)
Zuo H, Ueland P, Midttun O, Tell G, Fanidi A, Zheng W, et al.
Ann Oncol . 2019 Jan; 30(3):478-485. PMID: 30698666
Background: Increased vitamin B6 catabolism related to inflammation, as measured by the PAr index (the ratio of 4-pyridoxic acid over the sum of pyridoxal and pyridoxal-5'-phosphate), has been positively associated...
5.
No association between circulating concentrations of vitamin D and risk of lung cancer: an analysis in 20 prospective studies in the Lung Cancer Cohort Consortium (LC3)
Muller D, Hodge A, Fanidi A, Albanes D, Mai X, Shu X, et al.
Ann Oncol . 2018 Apr; 29(6):1468-1475. PMID: 29617726
Background: There is observational evidence suggesting that high vitamin D concentrations may protect against lung cancer. To investigate this hypothesis in detail, we measured circulating vitamin D concentrations in prediagnostic...
6.
Serum pepsinogen 1 and anti-Helicobacter pylori IgG antibodies as predictors of gastric cancer risk in Finnish males
Song M, Camargo M, Weinstein S, Murphy G, Freedman N, Koshiol J, et al.
Aliment Pharmacol Ther . 2017 Dec; 47(4):494-503. PMID: 29243850
Background: Serum pepsinogen 1 (SPG1) and anti-Helicobacter pylori serology have been used for gastric risk stratification in Asia. Aim: To assess utility of these markers in a Western population. Methods:...
7.
Association of 4p14 TLR locus with antibodies to Helicobacter pylori
Sung H, Camargo M, Yu K, Weinstein S, Morgan D, Albanes D, et al.
Genes Immun . 2015 Aug; 16(8):567-70. PMID: 26312625
A genome-wide association study among Europeans related polymorphisms of the Toll-like receptor (TLR) locus at 4p14 and the Fcγ receptor 2a locus at 1q23.3 to Helicobacter pylori serologic status. We...
8.
Elevated serum sCD23 and sCD30 up to two decades prior to diagnosis associated with increased risk of non-Hodgkin lymphoma
Purdue M, Lan Q, Kemp T, Hildesheim A, Weinstein S, Hofmann J, et al.
Leukemia . 2015 Jan; 29(6):1429-31. PMID: 25567136
No abstract available.
9.
Effects of α-tocopherol and β-carotene supplementation on liver cancer incidence and chronic liver disease mortality in the ATBC study
Lai G, Weinstein S, Taylor P, McGlynn K, Virtamo J, Gail M, et al.
Br J Cancer . 2014 Oct; 111(12):2220-3. PMID: 25314069
Background: Recent data suggest the possible benefits of α-tocopherol and β-carotene supplementation on liver cancer and chronic liver disease (CLD), but the long-term trial data are limited. Methods: We evaluated...
10.
Association of serum α-tocopherol, β-carotene, and retinol with liver cancer incidence and chronic liver disease mortality
Lai G, Weinstein S, Albanes D, Taylor P, Virtamo J, McGlynn K, et al.
Br J Cancer . 2014 Oct; 111(11):2163-71. PMID: 25314058
Background: Micronutrients may influence the development or progression of liver cancer and liver disease. We evaluated the association of serum α-tocopherol, β-carotene, and retinol with incident liver cancer and chronic...